PATENT CLAIM ANALYSIS

Application Number: 15947044
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["548", "560000"]

Abstract:
The present invention relates to Saroglitazar free acid of Formula (IA) or its pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable esters, stereoisomers, tautomers, analogs and derivatives thereof. The present invention also provides an amorphous form of saroglitazar free acid and processes of preparation thereof. The present invention also provides pharmaceutical composition comprising an amorphous form saroglitazar magnesium.

Claim (Index 4):
The saroglitazar free acid of Formula (IA) according to  claim 3 , wherein the amorphous form of saroglitazar free acid has an X-ray powder diffraction pattern substantially the same as that shown in  FIG. 5 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 91.0
- Lexical Diversity: 1.7
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14915457', '15366229', '14916402', '15748316', '14384567']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7789237829549704
- 35 USC 102 Novelty (BERT): 0.5794299497235638
- Combined Prediction Score: 0.7589743996318298
- Mean Citation Score: 454.359586
- Max Citation Score: 513.9902
- Similarity Product: 370.6554754747152

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test